EXOZ — EXOZYMES INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — |
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
| Fiscal year end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -1.19 | — | -1.19 | -1.19 | 1 | — |
| Dec 2027 | -1.12 | — | -1.12 | -1.12 | 1 | — |
| Dec 2028 | -0.47 | — | -0.47 | -0.47 | 1 | — |
| Dec 2029 | 0.42 | 8.3× | 0.42 | 0.42 | 1 | — |
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 9 SEC-registered investment managers reported holding EXOZ (EXOZYMES INC) in their latest 13F filings, with a combined reported value of $1.01M across 173.24K shares. That is +39.6% by share count (+49.14K shares) versus the previous quarter, while reported value moved -3.9%. Ownership is concentrated: the five largest holders account for 98.6% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 opened new positions, 3 added to existing stakes, 3 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of EXOZYMES INC (EXOZ) include VANGUARD CAPITAL MANAGEMENT LLC, Vanguard Group, GEODE CAPITAL MANAGEMENT, LLC, ranked by reported 13F value among the 16 institutional holders on this page.
EXOZ is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 9 | 173.24K | $1.01M | +39.6% |
| Q2 2026 | 10 | 147.71K | $1.25M | +57.8% |
| Q1 2026 | 7 | 62.90K | $471.81K | +0.7% |
| Q4 2025 | 7 | 62.60K | $682.35K | +4.5% |
| Q3 2025 | 6 | 59.92K | $880.36K | +9.2% |
| Q2 2025 | 9 | 75.38K | $727.44K | -29.7% |
| Q1 2025 | 6 | 76.77K | $802.22K | +5.8% |
| Q4 2024 | 7 | 98.10K | $1.62M | — |
Over the 8 quarters shown, institutional share counts increased 77% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2026 (+57.8%).
Top Institutional Holders (Q3 2026) — 9 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 108.73K | $630.65K | 0.00% | Add | |
| 23.26K | $134.92K | 0.00% | Reduce | |
| 18.00K | $104.94K | 0.04% | Reduce | |
| 11.35K | $66.18K | 0.00% | Add | |
| 9.43K | $54.67K | 0.00% | Hold | |
| 1.25K | $7.29K | 0.00% | Hold | |
| 1.21K | $7.07K | 0.00% | Add | |
| 8 | $47 | 0.00% | Reduce | |
| 1 | $6 | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 10 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 54.98K | $463.52K | 0.00% | Add | |
| 25.00K | $210.75K | 0.09% | New | |
| 23.41K | $197.31K | 0.00% | New | |
| 23.41K | $197.31K | 0.00% | Add | |
| 9.61K | $81.01K | 0.00% | Add | |
| 9.43K | $79.46K | 0.00% | Hold | |
| 1.25K | $10.54K | 0.00% | Hold | |
| 349 | $2.94K | 0.00% | Reduce | |
| 203 | $1.71K | 0.00% | Add | |
| 75 | $632 | 0.00% | New |
Q1 2026 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 22.19K | $166.43K | 0.00% | New | |
| 21.89K | $164.18K | 0.00% | Reduce | |
| 9.43K | $70.69K | 0.00% | New | |
| 6.80K | $51.05K | 0.00% | Add | |
| 1.32K | $9.89K | 0.00% | Add | |
| 1.25K | $9.39K | 0.00% | Hold | |
| 24 | $180 | 0.00% | Add |
Q4 2025 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 31.52K | $343.52K | 0.00% | Add | |
| 23.56K | $256.82K | 0.00% | Add | |
| 6.25K | $68.14K | 0.00% | Add | |
| 1.25K | $13.62K | 0.00% | Hold | |
| 17 | $185 | 0.00% | Reduce | |
| 3 | $33 | 0.00% | Reduce | |
| 2 | $22 | 0.00% | New |
Q3 2025 — 6 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 25.98K | $383.22K | 0.00% | Add | |
| 23.06K | $340.18K | 0.00% | Add | |
| 4.99K | $71.92K | 0.00% | Add | |
| 4.62K | $66.67K | 0.00% | Reduce | |
| 1.25K | $18.04K | 0.00% | Hold | |
| 23 | $332 | 0.00% | Reduce |
Q2 2025 — 9 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 23.15K | $222.28K | 0.00% | Reduce | |
| 20.60K | $197.75K | 0.00% | Hold | |
| 18.14K | $174.18K | 0.00% | New | |
| 5.01K | $49.54K | 0.00% | Add | |
| 4.84K | $47.83K | 0.00% | Add | |
| 2.00K | $19.76K | 0.00% | New | |
| 1.25K | $12.35K | 0.00% | New | |
| 344 | $3.40K | 0.00% | Reduce | |
| 36 | $356 | 0.00% | Add |
New Positions (Q3 2026)
Fully Exited (vs previous quarter)
- GEODE CAPITAL MANAGEMENT, LLC sold 23.41K sh · $197.31K
- UBS Group AG sold 203 sh · $1.71K
Fund Position History — shares by quarter (top 16 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 108.73K | 54.98K | 22.19K | — | — | — | — | — |
| Geode Capital Management | 23.26K | 23.41K | 21.89K | 23.56K | 23.06K | 20.60K | 20.60K | 16.76K |
| Davidson Kahn Capital Management, LLC | 18.00K | 25.00K | — | — | — | — | — | — |
| BlackRock Inc | 11.35K | 9.61K | 6.80K | 6.25K | 4.99K | 4.84K | 4.47K | — |
| VANGUARD FIDUCIARY TRUST CO | 9.43K | 9.43K | 9.43K | — | — | — | — | — |
| Morgan Stanley | 1.25K | 1.25K | 1.25K | 1.25K | 1.25K | 1.25K | — | — |
| Tower Research Capital LLC (TRC) | 1.21K | 349 | 1.32K | 2 | — | 344 | 1.13K | 389 |
| BARCLAYS PLC | 8 | 75 | — | — | — | — | — | — |
| Caitong International Asset Management Co., Ltd | 1 | — | — | — | — | — | — | — |
| Vanguard Group | — | — | — | 31.52K | 25.98K | 23.15K | 50.37K | 50.46K |
| Citadel Advisors | — | — | — | — | — | 18.14K | — | 27.65K |
| GEODE CAPITAL MANAGEMENT, LLC | — | 23.41K | — | — | — | — | — | — |
| UBS Group AG | — | 203 | 24 | 3 | 4.62K | 5.01K | 163 | 707 |
| BNP PARIBAS FINANCIAL MARKETS | — | — | — | — | — | — | — | 2.11K |
| RAYMOND JAMES FINANCIAL INC | — | — | — | — | — | 2.00K | — | — |
| Bank of America Corp | — | — | — | 17 | 23 | 36 | 31 | 15 |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold EXOZ?
As of 2026-Q3, 9 institutional funds reported holding EXOZ (EXOZYMES INC) in SEC 13F filings, with a combined reported value of $1.01M.
How many shares of EXOZ do institutions own?
13F filers reported 173.24K shares of EXOZ, worth $1.01M in aggregate at the end of 2026-Q3.
Is institutional ownership of EXOZ rising or falling?
Share counts moved +39.6% versus the prior quarter — accumulation.
Who are the top institutional holders of EXOZ?
The largest 13F holders are VANGUARD CAPITAL MANAGEMENT LLC, Vanguard Group, GEODE CAPITAL MANAGEMENT, LLC, Citadel Advisors, Geode Capital Management; the top 25 are ranked at the top of this page.
Who are the major shareholders of EXOZYMES INC?
The major shareholders of EXOZYMES INC (EXOZ) by reported 13F value are VANGUARD CAPITAL MANAGEMENT LLC, Vanguard Group, GEODE CAPITAL MANAGEMENT, LLC, Citadel Advisors, Geode Capital Management, among 16 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.